Compare LASR & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LASR | MMED |
|---|---|---|
| Founded | 2000 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.1B |
| IPO Year | 2018 | 2026 |
| Metric | LASR | MMED |
|---|---|---|
| Price | $73.45 | $11.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $54.31 | $22.56 |
| AVG Volume (30 Days) | ★ 1.2M | 577.4K |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.99 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $191,359,000.00 | N/A |
| Revenue This Year | $10.91 | $15.99 |
| Revenue Next Year | $14.32 | $10.00 |
| P/E Ratio | $7,841.94 | ★ N/A |
| Revenue Growth | ★ 38.09 | N/A |
| 52 Week Low | $15.05 | $10.65 |
| 52 Week High | $86.95 | $17.86 |
| Indicator | LASR | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 48.16 |
| Support Level | $64.78 | $10.65 |
| Resistance Level | $80.27 | $12.19 |
| Average True Range (ATR) | 6.23 | 0.74 |
| MACD | -0.24 | 0.15 |
| Stochastic Oscillator | 36.66 | 76.62 |
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products segment, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA, of which maximum revenue is derived from North America.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.